Loading company…
Signase, based in Houston, US, is a biopharmaceutical company developing protein tyrosine kinase inhibitors.
Signase is a biopharmaceutical company focused on the development of inhibitors of protein tyrosine kinases. Based in Houston, US, it is at the Seed stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in